|
|
Gene Vaccines) T2 J4 G3 W" D% p, U3 R: }4 F
Thalhamer, Josef; Weiss, Richard; Scheiblhofer, Sandra (Eds.)( N5 A! P d5 t3 C" ?" x- Y
1st Edition., 2012, XI, 330 p. 49 illus., 41 in color.
) d0 y% i3 ~, s4 H/ @$ O3 S& P% {& x7 e
Hardcover, ISBN 978-3-7091-0438-5
" q4 |; H T. yOnline orders shipping within 2-3 days' U4 B8 b$ A; U6 H; S. ^
149,95
# j& ]5 q! k# r6 ]6 G' B4 p! }* j+ Y, o, m, t1 b, R5 [" C7 n
目录7 P& U4 U1 j. U$ l( N+ h
Preface.- 1 General mechanisms of gene vaccines.- 2 Strategies to Improve DNA Vaccine Potency: HPV-associated Cervical Cancer as a Model System.- 3 Immune-activating mechanisms of replicase-based DNA and RNA vaccines and their role in immune-apoptosis.- 4 Cytokine genes as molecular adjuvants for DNA vaccines.- 5 Pharmaceutical non-viral formulations for gene vaccines.- 6 Rational design of formulated DNA vaccines: the DermaVir approach.- 7 In vivo electroporation.- 8 Electroporation-based Trigrid™ delivery system (TDS) for DNA vaccine administration.- 9 Prime Boost Regimens for Enhancing Immunity: Magnitude, Quality of Mucosal and Systemic Gene Vaccines.- 10 Intranodal genetic immunization.- 11 Immunotherapy of cancer with RNA vaccines.- 12 DNA and RNA vaccines for prophylactic and therapeutic treatment of type I allergy.- 13 Approved veterinary vaccines – paving the way to products for human use.- 14 Current status of regulations for DNA vaccines.- 15 State of the art production of antibiotic resistance-free plasmid DNA.- 16 Industrial Manufacturing of Plasmid-DNA Products for Gene Vaccination and Therapy.
1 F1 C+ ~- N. S9 B h* o% G, N8 T1 ]
$ P" }7 `- y+ T& w下载地址:9 O% `7 T- ?; T7 U$ X7 ?" P
& t- A3 w$ V+ r" q1 U) q* E
9 m( w2 R& o3 W4 h* i: }# l: G |
|